New strength of Salofalk

Dr Falk has launched a 1.5g sachet of Salofalk (mesalazine) granules.

The Salofalk granule range is indicated for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.

The new sachet strength contains 1.5g of gastro-resistant prolonged release mesalazine granules, offering simpler once-daily dosing of one or two sachets a day for the treatment of active ulcerative colitis.

View Salofalk drug record

Further information: Dr Falk


Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more